PANCAID

Yesterday, PANCAID members participated in the Hamburg Pankreasforum 2026, hosted at Universitätsklinikum Hamburg Eppendorf, bringing together top expertise in pancreatic health. 🩺🔬 #Pankreasforum #PancreaticCancer #Pancreas

New masterclass now available 🎥 Klaus Pantel & Catherine Alix-Panabières provide an in-depth overview of liquid biopsy diagnostics: From early detection to clinical implementation. Watch here: https://youtu.be/uFuAvdRABTo #LiquidBiopsy #CancerResearch #PANCAID

🚨 500,000 #pancreaticcancer deaths in 2020. The biggest challenge: We can’t diagnose it in time. #WorldCancerDay reminds us that every diagnosis remains a race against time And we’re committed to develop a biomarker panel that can reliably detect PDAC at its earliest stages #UnitedByUnique #WCD2026

What does “cell-free DNA” or “PanIN” mean? Our new PANCAID Glossary explains key #pancreaticcancer and research terms in clear, accessible language. 👉 pancaid-project.eu/for-patients... Thanks to all teams for input and to @pce-europe.bsky.social for checking the entries for accessibility!

Thrilled to welcome Queen Mary University of London (@qmul.bsky.social) as an associated partner in PANCAID! QMUL contributes to WP3 and WP2, bringing expertise in biomarker analysis and data-driven methods. #HorizonEU #MissionCancer

We’re excited to welcome Eberhard Karls University Tübingen (@unituebingen.bsky.social) to the PANCAID consortium! Their expertise in WP2 strengthens our biomarker research and supports progress in early detection of #pancreaticcancer. #HorizonEU

Honored to host the 3rd Annual Cluster Meeting of the Prevention & Early Detection (Screening) Cluster in Brussels. We're joined by our cluster members MammoScreen, DIOPTRA, SANGUINE, LUCIA, and @oncoscreen-project.bsky.social. @horizoneu.bsky.social @ec.europa.eu #CancerPrevention #EarlyDetection

In the afternoon sessions, we discuss work packages 1 – 3, first each progress separately, then jointly in a planum discussion. 1️⃣ Patient cohorts & sample collection 2️⃣ #liquidbiopsy diagnostis 3️⃣ AI analysis & data management #PancSky

We just had our PANCAID ECS session, where each ECS gave an update on their individual research projects. Thank you to Ebba Asplund, Kim-Lea Reese, Robert Wittram, Pabolo Villoslada-Blanco, Sergio Sabroso and Mireia Andueza for your presentations and contributions! #pancreaticcancer #earlydetection

Bonjour and goedendag from Brussels! Our 4th PANCAID General Assembly Meeting just kicked off with a masterclass shared by Klaus Pantel and Catherine Alix-Panabieres, on #Liquidbiopsy diagnostics #pancreaticcancer @cathiepana.bsky.social

🎙️Join us for the webinar “Approaches to Early Cancer Diagnosis & the Impact of #AIinOncology”  🗣️ Moderated by Federica Zanca, EIC Programme Manager  👥 Panelists:  @phireproject.bsky.social – Massimo Alfano  @pancaid.bsky.social  – @nuriamalats.bsky.social  #PANCAIM – John Hermans  #Webinar

🚀 Partner spotlight: @zavamed.bsky.social Leading telehealth platform ensure the readiness for a digital end-to-end patient pathway. Contributing to: 📍 WP1 – Patient cohort definition & biomaterial collection 📍 WP6 – Dissemination & communication #HorizonEurope #DigitalHealth #Telemedicine

It’s #RNAday! RNA, especially #microRNA, plays an important role in our research: Part of WP2 is profiling multi-omics data, where we analyse genomic, epigenomic, transcriptomic, microRNA and metabolomic data from #PDAC patients. #pancreaticcancer ➡️ https://pancaid-project.eu/research/work-packages/

🔬 This week’s #PANCAID partner spotlight: @regionstockholm.bsky.social (RS)! RS contributes to WP1 via Karolinska University Hospital, working with Prof. Löhr's group on clinical recruitment & biobanking. @hpb-karolinska.bsky.social @maloehr.bsky.social @ki.se #HorizonEurope #CancerResearch

🔦 #PANCAIDPartnerSpotlight: The University of Cambridge (via @cruk-ci.bsky.social) powers WP2 & WP3, and contributes expertise in circulating tumour DNA (ctDNA) analysis and multi-omic data integration. #CancerResearch #PancreaticCancer #EarlyDetection

🔦 #PANCAIDPartnerSpotlight: FIBIRYCIS brings expertise in #LiquidBiopsy, cancer genetics & PDAC biomarkers to WP1 – supporting sample & data collection across pancreatic lesions. Part of the Ramón y Cajal Health Research Institute. #CancerResearch #PancreaticCancer #EarlyDetection

🔦 This week’s #PANCAIDPartnerSpotlight: KSM Innovation / MACCABI KSM's strengths are: 📊 Access to 30+yrs of digital health data from 2.7M members 🧬 900K biobank samples In PANCAID, they contribute to WP1 by providing blood samples #HealthData #CancerDetection #Biobank

🔦 PANCAID Partner Spotlight: @collectiveminds.bsky.social Co-Leading WP3: Data management & AI 🔍 CMR powers our secure, multimodal data infrastructure: 📊 Repository design 🔐 Privacy & governance #PANCAID #DataManagement #CancerResearch

🔦 PANCAID Partner Spotlight: @hebrewuniversity.bsky.social The Dor & Kaplan labs lead epigenetic and ML innovation for PANCAID. 🔬 Dor Group: cfDNA tissue-of-origin via DNA methylation 🧠 Kaplan Group: Multi-omics modeling with advanced machine learning #CancerDetection #PancreaticCancer

🔦 PANCAID Partner Spotlight: @uu.se The labs of @masoodkamali.bsky.social & @globischlab.bsky.social bring cutting-edge EV, proteomics & metabolomics expertise to PANCAID. 🟣 Working together on biomarker discovery in WP2. @scilifelab.se #Metabolomics #CancerResearch

🔦 PANCAID Partner Spotlight: University Hospital Heidelberg (UKHD) UKHD’s European Pancreas Center (EPZ) provides key biosamples & serum proteomics for PANCAID. With 10k+ samples in PancoBank, their biobank is critical to early detection research. #PancreaticCancer #Proteomics

📢 New review from PANCAID's WP4: Cost-effectiveness of #earlydetection in #pancreaticcancer 🧾💶 ➡️ Some strategies work well, but inconsistencies in methods limit broader conclusions. Read the full paper: link.springer.com/article/10.1... @drchrisbrett.bsky.social #HealthEconomics

🧠 Midpoint check-in! Today, PANCAID held its 6th Steering Committee meeting as we hit the halfway mark of our #HorizonEU project. WP leads aligned strategy & next steps for advancing early #PancreaticCancer detection. We’re buzzing for what’s ahead! ⚡ #CancerResearch #LiquidBiopsy

🔦 PANCAID Partner Spotlight: CHU de Montpellier At LCCRH, CHUM pioneers CTC research to drive early cancer detection. They support WP2, WP3 & WP6: from biomarker discovery to data science and training young researchers. @cathiepana.bsky.social #LiquidBiopsy #CancerResearch #PancreaticCancer

🧬 New research: Fecal #metabolomics reveals key differences between autoimmune & chronic pancreatitis, unlocking potential for novel diagnostics! 📄 Read the study: onlinelibrary.wiley.com/doi/full/10.... @maloehr.bsky.social @globischlab.bsky.social #PancreaticCancer #Biomarkers #liquidbiopsy

🔦 PANCAID Partner Spotlight: #UKSH UKSH co-leads WP1 in PANCAID: Defining patient cohorts & guiding biomaterial collection. With 650+ cancer & 100+ control samples from TRIBanK, they power biomarker discovery for early #pancreaticcancer detection. @sebens-iet-kiel.bsky.social

🔦 PANCAID Partner Spotlight: @concentris.bsky.social As project office & WP6 lead, concentris keeps PANCAID running smoothly, from coordination to communication, training & impact. Their expert team supports EU research from start to finish. #ResearchManagement #SciComm #HorizonEurope

🔦 PANCAID Partner Spotlight: @pce-europe.bsky.social PCE co-leads PANCAID's communication & dissemination efforts (WP6), ensuring research reaches patients, policymakers & the public. Their work unites 80+ European experts to improve survival & awareness. #PancreaticCancer #Advocacy

🔦 #PANCAIDPartnerSpotlight: @umeauniversitet.bsky.social 🇸🇪 With unique prediagnostic & diagnostic biobank samples & translational research, Umeå contributes to PANCAID: 📦 WP1: Biomarkers + biobanking 🧭 WP5: Ethical insight from clinical care @malinasund.bsky.social @danielohlund.bsky.social

🔦 This week in our #PANCAIDPartnerSpotlight: @medunigraz.at 🔬 Experts in ctDNA & multi-omics 🧪 Driving #LiquidBiopsy innovations ⚡ Active across 4 PANCAID work packages! Pushing boundaries in early #PancreaticCancer detection. #Genomics

🔦This week in our #PANCAIDPartnerSpotlight: @cniostopcancer.bsky.social 🧬GMEG (@nuriamalats.bsky.social) leads AI-driven biomarker discovery 🧪Peinado Lab (@hps2022.bsky.social) pioneers exosome-based diagnostics Both teams are vital to our mission: a blood test for early #PancreaticCancer detection

🔦 PANCAID Partner Spotlight: @ki.se Co-coordinator of #PANCAID, KI leads clinical trials, ethical research & economic modelling: 🧪 #Pancreaticcancer expertise 🧠 #Ethics & QoL in screening 💰 Budget impact studies @maloehr.bsky.social @raiheu.bsky.social #HealthEconomics #CancerResearch

🔦 PANCAID Partner Spotlight: UKE Hamburg! 👨‍⚕️ Institute of Tumor Biology (ITB): Coordinates the project & advances liquid biopsy 📊 Department of Health Economics & Health Services Research (IGV) leads WP4: Modelling of #EarlyDetection Strategies & Health Economics #CancerResearch #PancreaticCancer

🔦 Kicking off the PANCAID #PartnerSpotlight! We unite 18 institutions across 8 countries to advance #earlydetection of #pancreaticcancer. Each week, we’ll highlight one of our partners and their role in the project. Stay tuned to meet the teams behind the research! 👥 #CancerResearch

Our second meeting day morning included: ▪️WP1-3 discussions ▪️WP5 update on #ethics by Y. Wengström & G. Marras ▪️WP6: #sciencecomm by T. Berghammer ▪️Impact board & IP by D. Smit ▪️Feedback by our SEAB members G. Chassang, E. Aas, S. Srivastava

We started into the afternoon session with our work package progress updates, beginning with WP1: defining patient cohorts and collection of #biomaterial WP2: #liquidbiopsy analysis WP 3: data management and AI analysis #datamanagement #AI

We just had our Early Career Scientists (ECS) session! Each young researcher, being an invaluable part of the project, presented their progress and next steps, while receiving valuable feedback from the consortium members. #careerdevelopment #pancreaticcancer

Excited for PANCAID’s 3rd General Assembly this week in Brussels! 🇧🇪 @maloehr.bsky.social @malinasund.bsky.social @cniostopcancer.bsky.social @hps2022.bsky.social @globischlab.bsky.social @qmul.ac.uk @collectiveminds.bsky.social #PANCAID #HorizonEurope #PancreaticCancer

As the year comes to a close, let’s reflect. It's been a year full of progress. Some highlights: ✅published 4 scientific reviews ✅launched a video series ✅strengthened collaborations Thank you all for your support this year! 🎄 Wishing you happy holidays and a fantastic 2025! 🌟 #pancreaticcancer

Earlier this week, PANCAID's coordinator Klaus Pantel joined an #EUHPP policy webinar as a guest speaker on the EU Cancer Mission project cluster on #CancerPrevention. Klaus participated in a panel session on Innovation in Cancer Screening – New Technologies. #EUHealth @ec.europa.eu

Exciting news! 📢 PANCAID’s third newsletter is out now! Missed it? No worries – just read it online: mailchi.mp/0509e7094957... 🎉 Sign up to stay updated with the latest developments: eepurl.com/it4vC6 #PANCAID #PancreaticCancer #EarlyDetection #LiquidBiopsy #HorizonEurope #CancerResearch